|
Volumn 19, Issue 12, 2013, Pages 1411-1412
|
Therapeutic vaccination of a liver transplant recipient suffering from fulminant hepatitis B during pregnancy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CATECHOLAMINE DERIVATIVE;
CEFAZOLIN;
HEPATITIS B ANTIBODY;
HEPATITIS B VACCINE;
LAMIVUDINE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
TACROLIMUS;
VITAMIN K GROUP;
ABDOMINAL RADIOGRAPHY;
ADULT;
ANTIVIRAL THERAPY;
ARTIFICIAL VENTILATION;
CASE REPORT;
ECHOGRAPHY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
GRAFT RECIPIENT;
HEPATITIS B;
HEPATITIS B VIRUS;
HLA MATCHING;
HOSPITALIZATION;
HUMAN;
IMMUNIZATION;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION PREVENTION;
KIDNEY FAILURE;
LABORATORY TEST;
LETTER;
LIVER FAILURE;
LIVER FUNCTION TEST;
LIVER GRAFT REJECTION;
LIVER TRANSPLANTATION;
PREGNANT WOMAN;
PRIORITY JOURNAL;
RISK FACTOR;
TREATMENT DURATION;
ADULT;
FEMALE;
HEPATITIS B;
HEPATITIS B ANTIBODIES;
HEPATITIS B VACCINES;
HUMANS;
IMMUNIZATION SCHEDULE;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
TIME FACTORS;
TREATMENT OUTCOME;
VACCINATION;
|
EID: 84889091068
PISSN: 15276465
EISSN: 15276473
Source Type: Journal
DOI: 10.1002/lt.23751 Document Type: Letter |
Times cited : (7)
|
References (5)
|